FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045173804> ?p ?o ?g. }

• W2045173804 endingPage "432" @default.
• W2045173804 startingPage "425" @default.
• W2045173804 abstract "The antihypertensive efficacy of the angiotensin II receptor blocker olmesartan medoxomil has been shown to compare favourably with that of other antihypertensive agents. This randomized, double-blind study compared the antihypertensive efficacy of the starting dose of olmesartan medoxomil with that of the calcium channel blocker amlodipine besylate (amlodipine) in subjects with mild-to-moderate hypertension. Following a 4-week, single-blind, placebo run-in period, 440 subjects aged >/=18 years were randomized to the starting dose of olmesartan medoxomil (20 mg/day), amlodipine (5 mg/day), or placebo for 8 weeks. Subjects were evaluated by 24-h ambulatory blood pressure monitoring (ABPM) and by seated cuff blood pressure (BP) measurements at trough. The primary end point was the change from baseline in mean 24-h diastolic blood pressure (DBP) by ABPM at Week 8. Secondary end points included change from baseline in mean 24-h ambulatory systolic blood pressure (SBP) at 8 weeks, change from baseline in mean seated trough cuff DBP and SBP measurements, and response and control rates for DBP <90 and <85 mmHg. Control rates for SBP <140 and <130 mmHg were also calculated. Olmesartan medoxomil and amlodipine produced significantly greater reductions in ambulatory and seated DBP and SBP compared with placebo. Mean reductions in ambulatory and seated BP were similar between the two active agents; however, in the olmesartan medoxomil group, significantly more patients achieved the SBP goal of <130 mmHg and the DBP goal of <85 mmHg. Both drugs were well tolerated at the recommended starting dose. Although amlodipine was associated with a higher incidence of oedema, this did not reach statistical significance. Olmesartan medoxomil is an effective antihypertensive agent, with BP-lowering efficacy at the starting dose similar to that of amlodipine, and is associated with more patients achieving the rigorous BP goals of SBP <130 mmHg and DBP <85 mmHg." @default.
• W2045173804 created "2016-06-24" @default.
• W2045173804 creator A5028366409 @default.
• W2045173804 creator A5059669057 @default.
• W2045173804 creator A5076355849 @default.
• W2045173804 date "2003-05-23" @default.
• W2045173804 modified "2023-10-18" @default.
• W2045173804 title "Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension" @default.
• W2045173804 cites W1964708937 @default.
• W2045173804 cites W1966000112 @default.
• W2045173804 cites W1972736384 @default.
• W2045173804 cites W1979343843 @default.
• W2045173804 cites W1982920623 @default.
• W2045173804 cites W2017349574 @default.
• W2045173804 cites W2038286610 @default.
• W2045173804 cites W2040463508 @default.
• W2045173804 cites W2049397775 @default.
• W2045173804 cites W2055909650 @default.
• W2045173804 cites W2066070093 @default.
• W2045173804 cites W2086214954 @default.
• W2045173804 cites W2087203190 @default.
• W2045173804 cites W2090798025 @default.
• W2045173804 cites W2100082183 @default.
• W2045173804 cites W2100767767 @default.
• W2045173804 cites W2133217116 @default.
• W2045173804 cites W2137408480 @default.
• W2045173804 cites W2161316366 @default.
• W2045173804 cites W2332833873 @default.
• W2045173804 cites W2977629971 @default.
• W2045173804 cites W3022929210 @default.
• W2045173804 cites W3198570063 @default.
• W2045173804 doi "https://doi.org/10.1038/sj.jhh.1001577" @default.
• W2045173804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12764406" @default.
• W2045173804 hasPublicationYear "2003" @default.
• W2045173804 type Work @default.
• W2045173804 sameAs 2045173804 @default.
• W2045173804 citedByCount "75" @default.
• W2045173804 countsByYear W20451738042012 @default.
• W2045173804 countsByYear W20451738042013 @default.
• W2045173804 countsByYear W20451738042014 @default.
• W2045173804 countsByYear W20451738042015 @default.
• W2045173804 countsByYear W20451738042016 @default.
• W2045173804 countsByYear W20451738042017 @default.
• W2045173804 countsByYear W20451738042018 @default.
• W2045173804 countsByYear W20451738042019 @default.
• W2045173804 countsByYear W20451738042020 @default.
• W2045173804 countsByYear W20451738042022 @default.
• W2045173804 crossrefType "journal-article" @default.
• W2045173804 hasAuthorship W2045173804A5028366409 @default.
• W2045173804 hasAuthorship W2045173804A5059669057 @default.
• W2045173804 hasAuthorship W2045173804A5076355849 @default.
• W2045173804 hasBestOaLocation W20451738041 @default.
• W2045173804 hasConcept C126322002 @default.
• W2045173804 hasConcept C126894567 @default.
• W2045173804 hasConcept C142724271 @default.
• W2045173804 hasConcept C149323552 @default.
• W2045173804 hasConcept C164705383 @default.
• W2045173804 hasConcept C204787440 @default.
• W2045173804 hasConcept C27081682 @default.
• W2045173804 hasConcept C2779646130 @default.
• W2045173804 hasConcept C2779766728 @default.
• W2045173804 hasConcept C2780356492 @default.
• W2045173804 hasConcept C35785553 @default.
• W2045173804 hasConcept C71924100 @default.
• W2045173804 hasConcept C84393581 @default.
• W2045173804 hasConcept C98274493 @default.
• W2045173804 hasConceptScore W2045173804C126322002 @default.
• W2045173804 hasConceptScore W2045173804C126894567 @default.
• W2045173804 hasConceptScore W2045173804C142724271 @default.
• W2045173804 hasConceptScore W2045173804C149323552 @default.
• W2045173804 hasConceptScore W2045173804C164705383 @default.
• W2045173804 hasConceptScore W2045173804C204787440 @default.
• W2045173804 hasConceptScore W2045173804C27081682 @default.
• W2045173804 hasConceptScore W2045173804C2779646130 @default.
• W2045173804 hasConceptScore W2045173804C2779766728 @default.
• W2045173804 hasConceptScore W2045173804C2780356492 @default.
• W2045173804 hasConceptScore W2045173804C35785553 @default.
• W2045173804 hasConceptScore W2045173804C71924100 @default.
• W2045173804 hasConceptScore W2045173804C84393581 @default.
• W2045173804 hasConceptScore W2045173804C98274493 @default.
• W2045173804 hasIssue "6" @default.
• W2045173804 hasLocation W20451738041 @default.
• W2045173804 hasLocation W20451738042 @default.
• W2045173804 hasOpenAccess W2045173804 @default.
• W2045173804 hasPrimaryLocation W20451738041 @default.
• W2045173804 hasRelatedWork W2019134976 @default.
• W2045173804 hasRelatedWork W2045173804 @default.
• W2045173804 hasRelatedWork W2053932973 @default.
• W2045173804 hasRelatedWork W2055006209 @default.
• W2045173804 hasRelatedWork W2379834714 @default.
• W2045173804 hasRelatedWork W2418295235 @default.
• W2045173804 hasRelatedWork W2426285380 @default.
• W2045173804 hasRelatedWork W2433024577 @default.
• W2045173804 hasRelatedWork W2890378230 @default.
• W2045173804 hasRelatedWork W3028927003 @default.
• W2045173804 hasVolume "17" @default.
• W2045173804 isParatext "false" @default.
• W2045173804 isRetracted "false" @default.

• next